Is it Common to be First Diagnosed with MS at Age 67?
No, it is uncommon to receive a first diagnosis of multiple sclerosis at age 67, though it does occur in a small but meaningful proportion of cases. Late-onset MS (defined as clinical onset after age 50) represents approximately 5% of all MS diagnoses, and diagnosis at age 67 would place a patient well beyond even this late-onset threshold 1.
Epidemiology of Late-Onset MS
The proportion of MS cases with onset after age 50 is approximately 5% (95% CI: 3.78% to 6.57%) based on meta-analysis of multiple studies 1.
Even more specifically, only 4.6% of MS patients in one large cohort had first symptoms after age 50, with a mean age at onset of 53.5 years (range 50-62 years) 2.
The proportion of MS onset after age 50 has been increasing over time, rising from 2.6% before 1970 to 11.9% after 2010, suggesting this is becoming slightly more common than historically observed 3.
At age 67, a patient would be in the extreme tail of the age distribution for MS onset, making this diagnosis quite rare but not impossible 4, 2.
Critical Diagnostic Considerations at This Age
The 2024 MAGNIMS-CMSC-NAIMS consensus guidelines specifically emphasize that late-onset MS (defined as clinical onset >50 years) requires special diagnostic consideration due to the high frequency of mimics 5.
Key Diagnostic Challenges:
Deep and periventricular white matter lesions are extremely common with normal aging, vascular comorbidities, and migraine in this age group, making MRI interpretation more challenging 5.
The absence of spinal cord lesions should trigger strong consideration of alternative diagnoses, especially in older patients with cardiovascular risk factors 5.
For patients aged 45 years or older, detecting at least three periventricular lesions (rather than just one) improves diagnostic specificity while preserving accuracy 5.
Diagnostic Features That Support MS Over Mimics:
Cortical lesions are common in MS but have not been observed in migraine, making their presence supportive of MS 5.
Peripheral pontine lesions make MS more likely than central pontine lesions in older individuals with vascular risk factors 5.
The central vein sign (CVS) remains valid even in older individuals: more than 40% of lesions being CVS-positive correctly identifies nearly all people with MS, though the proportion decreases with age and vascular comorbidities 5.
Incidental T2-hyperintense lesions are exceedingly rare in the spinal cord, so their presence strongly supports a demyelinating process 5.
Clinical Presentation Differs at This Age
Motor symptoms become increasingly predominant as the presenting feature with advancing age, occurring in 61.5% of patients with onset ≥50 years compared to only 19.3% in those <30 years 4.
Progressive myelopathy is a common but not exclusive clinical syndrome at diagnosis in older patients 6.
Visual and sensory symptoms, which account for nearly half of first manifestations in younger patients, affect a significantly lower proportion of the oldest age group 4.
Progressive forms of MS, especially primary progressive MS, are much more common with late onset: 51.3% of patients ≥50 years had primary progressive MS compared to 0% in those <30 years 4.
Despite older age, relapsing-remitting MS still occurs in approximately 33-50% of late-onset cases, and active inflammation (clinical relapses and gadolinium enhancement) occurs in a significant number 6, 2.
Diagnostic Delay is a Major Problem
The time needed to confirm MS diagnosis becomes significantly longer with increasing age: median time was 26 months (IQR 12-60) for patients ≥50 years compared to only 7 months (IQR 2-25) for those <30 years 4.
This diagnostic delay likely reflects both the increased complexity of differential diagnosis and lower clinical suspicion for MS in older adults 4.
Clinicians must maintain a high index of suspicion even in this age group when typical features are present, as delayed diagnosis can lead to inappropriate management and preventable complications 1.
Prognosis is Generally Worse
Progression to disability is more rapid in late-onset MS, with a mean Progression Index of 0.81 suggesting rapid neurological deterioration 2.
Expanded Disability Status Scale (EDSS) at diagnosis is significantly higher with advancing age: median EDSS was 3.5 (IQR 3-5) for patients ≥50 years compared to 2 (IQR 1.5-3) for those <30 years 4.
After a mean disease duration of 7.6 years, there is marked increase in sphincteric and cerebellar involvement in late-onset cases 2.
Common Pitfalls to Avoid
Do not dismiss MS solely based on age—while uncommon, it does occur and requires the same rigorous diagnostic approach 1, 6.
Do not over-interpret white matter lesions as MS without meeting stricter criteria (≥3 periventricular lesions, presence of cortical lesions, spinal cord involvement) 5.
Do not assume all late-onset cases are primary progressive—approximately one-third to one-half remain relapsing-remitting and may benefit from different therapeutic approaches 6, 2.
Actively exclude vascular disease, neurosarcoidosis, and other age-related mimics before confirming MS diagnosis 5.